Skip to main content
Clinical Trials/NCT03078153
NCT03078153
Completed
Not Applicable

The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC

George Washington University1 site in 1 country57 target enrollmentApril 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pre-Exposure Prophylaxis
Sponsor
George Washington University
Enrollment
57
Locations
1
Primary Endpoint
Adherence To Truvada
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.

Registry
clinicaltrials.gov
Start Date
April 1, 2017
End Date
December 15, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marc O. Siegel

Principal Investigator

George Washington University

Eligibility Criteria

Inclusion Criteria

  • Male assigned at birth (regardless of current gender identity)
  • Age 18-24
  • Black/African American, Latino or Asian
  • HIV negative
  • History of unprotected anal sex with a man in the last 6 months
  • Living within the DC metropolitan statistical area and anticipate remaining within the DC area for the next 6 months
  • Not enrolled in any other HIV prevention trial
  • Interested in taking PrEP
  • Not a current PrEP user and have not taken PrEP in the last 30 days
  • Able to provide informed consent

Exclusion Criteria

  • Female sex at birth
  • Age younger than 18 or older than 24
  • Caucasian
  • HIV positive
  • Actively taking PrEP or having taken PrEP within 30 days of enrollment
  • Chronic hepatitis B infection
  • Known renal insufficiency
  • On probation or parole
  • Any other conditions that the Principal Investigator may consider a contraindication to enrolling in the study

Outcomes

Primary Outcomes

Adherence To Truvada

Time Frame: 6 months

Level of Truvada drug levels inside red blood cells (performed by dried blood spots)

Secondary Outcomes

  • New Cases of HIV(6 months)
  • Incidence of STIs(6 months)

Study Sites (1)

Loading locations...

Similar Trials